Chapter 6: Adrenergic Receptor Agonists and Antagonists Flashcards

(69 cards)

1
Q

What are the 3 classifications of sympathomimetic drugs?

A

1st Group (Direct Agonists), 2nd Group (Indirect Agonists), 3rd Group (Mixed-Acting Adrenergic Agonists)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Drugs that mimic the physiological and pharmacological actions of the endogrnous catecholamines

A

Sympathomimetic Drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Classification of sympathomimetic drugs that directly binds to and activate adrenergic receptors

A

1st Group or Direct Agonists

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Examples of 1st group or direct agonists

A

Phenylephrine, Dobutamine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

This group enhances the availability of endogenous catecholamines to bind adrenergic receptors

A

2nd Group (indirect Acting Agonists

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Group of drugs that directly activate adrenergic receptors as well as increase the release of NE from adrenergic nerve terminals

A

3rd Group (Mixed-Acting Adrenergic Agonists)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Main neurotransmitters utilized by the SNS

A

Epinephrine, Norepinephrine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Parent comound of sympathomimetic amines, consists of benzene ring and ethylamine side

A

B-phenylethylamine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Sympathomimetic drugs

A

Epinephrine, Norepinephrine, Dopamine, Isoproterenol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Required for maximum alpha and beta receptor potencies

A

Catechol nucleus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Any chemical containing catechol

A

Catecholamines

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Modification in phenylethylthalamine that results in reduced B-adrenergic receptor activity

A

removal of hydroxyl group

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Modification in phenylethylthalamine that produces a compound with reduced CNS effects

A

Substitution of B-carbon atoms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Modification in phenylethylthalamine that produces a drug that is generally more resistant to oxidation by monoamine oxidase

A

Substitution of a-carbon atom

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Modification in phenylethylthalamine that affects a nd B agonistic properties of various drugs

A

Alkyl substitutions on the amino acid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

A type of G-coupled receptor

A

Adrenergic Receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Members of the B-adrenergic receptor family

A

B1, B2, B3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Activation of this receptor results in stimulation of adenylyl cyclase and increase cAMP

A

B-adrenergic receptor family

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

B-adrenergic receptor that increase heart rate and enhance cardiac contractility

A

B1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

B-adrenergic receptor found in the pulmonary airways

A

B2 receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

B-adrenergic receptors found in the detrusor muscle of the bladder

A

B2 and B3 receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Members of the a1 receptor family

A

A1A, A1B, A1D

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

This receptor family activates phospholipase C

A

a1 receptor family

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Where are a1 receptors located?

A

vascular smooth muscles

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Function of the a1 receptor
smooth muscle contraction
26
Members of the a2 receptor family
A2A, A2B, and A2C
27
Activation of these receptor inhibits adenyl cyclase activity, hence, a reduced cAMP levels
a2 receptors
28
Location of a2 receptors
terminals of postganglionic sympathetic nerve fibers
29
Activation of this receptor will reduce norepinephrine release from nerve terminals
a2 receptors
30
This receptor is expressed at the thrombocytes, endothelial cells, and CNS
a2 receptors
31
Members of the dopamine receptors
D1, D2
32
Activation of this dopamine receptor is associated with increased cAMP
D1 receptor activation
33
Activation of this dopamine receptor inhibits adenyl cyclase activity
D2 receptor activation
34
Provides an important framework for understanding target organ effects of endogenous catecholamines and sympathomimetic drugs
Receptor Selectivity
35
A potent and selective agonist at A1 adrenergic receptors
Phenylephrine
36
Drug that can cause an increase in peripheral vascular resistance, hence, an increase in blood pressure
Phenylephrine
37
An agonist at a1, a2, and b1 adrenergic receptors
Norepinephrine
38
A potent agonist at a-adrenergic and b-adrenergic receptors
Epinephrine
39
Produces vasodilation when bound to B2 receptors
Epinephrine
40
Used for downer patients
Epinephrine
41
Has competing vasoconstriction and vasodilation effects
Epinephrine
42
A potent nonselective B1 and B2 receptor agonists that exerts little effect on A-adrenergic receptors
Isoproterenol
43
Used for hypertensive patients
Isoproterenol
44
Blocks adrenergic receptors
Adrenergic-Receptor Antagonists
45
Used in veterinary medicine to reverse sedation caused by a2-adrenergic receptor agonist
A2-Adrenergic receptor Antagonist
46
Non-selective antagonist that bind covalently to a-adrenergic receptors to produce an irreversible bond
Phenoxybenzamine
47
Inhibition of reuptake of Norepinephrine at presynaptic nerve terminals is an effect of?
Phenoxybenzamine
48
What are some exampls of non-seslective a1, a2-adrenergic receptor antagonists?
1. Phenoxybenzamine 2. Phentolamine 3. Phenothiazine tranquilizers
49
Potent nonselective a-adrenergic receptor antagonists, have profound CNS effect
Phenothiazine tranquilizers
50
Used in dogs, can antagonize a1 drenergic receptors
Trazodone
51
A competitive antagonist marked selectivity for a1-adrenergic receptor
Prasozin
52
Reversible a1-adrenergic receptor antagonists with similar effects to prazosin
Terazosin, Doxazosin, Alfuzosin
53
A second generation A1 adrenergic receptor antagonist, used for orthostatic hypotension
Tamsulosin
54
A1 adrenergic receptor antagonist that has higher affinity for A1A and A1D receptors
Tamsulosin
55
Third generation, highly selective A1 adrenergic receptro antagonist
Silodosin
56
The prototype for selective A2 adrenergic receptor antagonists
Yohimbine
57
Yohimbe can be found in the bark of ______ and root of _______
Pausinystalia yohimbe, Rauwolfia root
58
Demonstrates a degree of antagonistic activity at serotonin receptors
Yohimbine
59
Belongs to the synthetic group of competitive A2 adrenergic receptor antagonist
Tolazoline
60
Licensed for reversing xylazine in horses
Tolazoline
61
A mixed A1 and A2 adrenergic receptor antagonist
Tolazoline
62
An A2 adrenergic receptor antagonist with an imidazole structure
Atipamezole
63
Has binding affinity and A2/A1 selectivity ratio higher than those of yohimbine or tolazoline
Atipamezole
64
Group of beta blockers that can stimulate beta-adrenergic receptors (agonist effect) and oppose catecholamines (antagonistic effect) in a competitive way
Intrinsic Sympathomimetic Activity (ISA)
65
Drugs considered as partial antagonists
Pindolol, Acebutolol
66
Cause incomplete activation of B receptors
Partial Antagonists
67
Inhibit the activation of B-adrenergic receptors in the presence of high levels of Epinephrine and Norepinephrine
Partial Antagonists
68
Beta blockers used in veterinary medicine
Propranolol, Atenolol, Esmolol, Metoprolol, Carvedilol
69
Classifications of beta blockers
1. Nonselective B-adrenergic receptor antagonists (1st Generation) 2. Selective B1-ddrenergic receptor antagonists (2nd Generation) 3. Third Generation Nonselective Antagonists